vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Grindr Inc. (GRND). Click either name above to swap in a different company.

Grindr Inc. is the larger business by last-quarter revenue ($126.0M vs $85.1M, roughly 1.5× 4D Molecular Therapeutics, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 16.1%, a 6.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 29.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $24.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 29.3%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

Grindr is a location-based social networking and online hookup application for LGBTQ people.

FDMT vs GRND — Head-to-Head

Bigger by revenue
GRND
GRND
1.5× larger
GRND
$126.0M
$85.1M
FDMT
Growing faster (revenue YoY)
FDMT
FDMT
+8508871.0% gap
FDMT
8508900.0%
29.0%
GRND
Higher net margin
FDMT
FDMT
6.7% more per $
FDMT
22.8%
16.1%
GRND
More free cash flow
FDMT
FDMT
$3.9M more FCF
FDMT
$28.5M
$24.5M
GRND
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
29.3%
GRND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDMT
FDMT
GRND
GRND
Revenue
$85.1M
$126.0M
Net Profit
$19.4M
$20.3M
Gross Margin
Operating Margin
17.3%
24.9%
Net Margin
22.8%
16.1%
Revenue YoY
8508900.0%
29.0%
Net Profit YoY
139.1%
116.4%
EPS (diluted)
$0.43
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
GRND
GRND
Q4 25
$85.1M
$126.0M
Q3 25
$90.0K
$115.8M
Q2 25
$15.0K
$104.2M
Q1 25
$14.0K
$93.9M
Q4 24
$1.0K
$97.6M
Q3 24
$3.0K
$89.3M
Q2 24
$5.0K
$82.3M
Q1 24
$28.0K
$75.3M
Net Profit
FDMT
FDMT
GRND
GRND
Q4 25
$19.4M
$20.3M
Q3 25
$-56.9M
$30.8M
Q2 25
$-54.7M
$16.6M
Q1 25
$-48.0M
$27.0M
Q4 24
$-123.9M
Q3 24
$-43.8M
$24.7M
Q2 24
$-35.0M
$-22.4M
Q1 24
$-32.4M
$-9.4M
Operating Margin
FDMT
FDMT
GRND
GRND
Q4 25
17.3%
24.9%
Q3 25
-67983.3%
39.1%
Q2 25
-396373.3%
23.4%
Q1 25
-383007.1%
27.0%
Q4 24
20.9%
Q3 24
-1704400.0%
31.8%
Q2 24
-849120.0%
29.8%
Q1 24
-136200.0%
25.6%
Net Margin
FDMT
FDMT
GRND
GRND
Q4 25
22.8%
16.1%
Q3 25
-63195.6%
26.6%
Q2 25
-364386.7%
16.0%
Q1 25
-342657.1%
28.8%
Q4 24
-126.9%
Q3 24
-1461433.3%
27.6%
Q2 24
-699060.0%
-27.2%
Q1 24
-115717.9%
-12.5%
EPS (diluted)
FDMT
FDMT
GRND
GRND
Q4 25
$0.43
$0.10
Q3 25
$-1.01
$0.16
Q2 25
$-0.98
$0.08
Q1 25
$-0.86
$0.09
Q4 24
$-0.65
Q3 24
$-0.79
$0.09
Q2 24
$-0.63
$-0.13
Q1 24
$-0.66
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
GRND
GRND
Cash + ST InvestmentsLiquidity on hand
$402.7M
$87.0M
Total DebtLower is stronger
$395.9M
Stockholders' EquityBook value
$505.7M
$47.0M
Total Assets
$566.7M
$531.0M
Debt / EquityLower = less leverage
8.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
GRND
GRND
Q4 25
$402.7M
$87.0M
Q3 25
$305.1M
$6.3M
Q2 25
$293.2M
$120.8M
Q1 25
$321.4M
$255.9M
Q4 24
$424.9M
$59.2M
Q3 24
$501.9M
$39.1M
Q2 24
$541.9M
$16.3M
Q1 24
$525.9M
$21.5M
Total Debt
FDMT
FDMT
GRND
GRND
Q4 25
$395.9M
Q3 25
$279.9M
Q2 25
$283.5M
Q1 25
$287.0M
Q4 24
$290.6M
Q3 24
$294.1M
Q2 24
$297.7M
Q1 24
$315.0M
Stockholders' Equity
FDMT
FDMT
GRND
GRND
Q4 25
$505.7M
$47.0M
Q3 25
$369.0M
$71.0M
Q2 25
$420.9M
$187.7M
Q1 25
$469.7M
$319.8M
Q4 24
$510.6M
$-131.6M
Q3 24
$552.9M
$-13.4M
Q2 24
$588.3M
$-41.7M
Q1 24
$600.6M
$-22.0M
Total Assets
FDMT
FDMT
GRND
GRND
Q4 25
$566.7M
$531.0M
Q3 25
$424.0M
$439.2M
Q2 25
$473.6M
$547.6M
Q1 25
$515.7M
$679.4M
Q4 24
$560.4M
$479.1M
Q3 24
$604.0M
$456.3M
Q2 24
$620.1M
$435.0M
Q1 24
$629.9M
$437.7M
Debt / Equity
FDMT
FDMT
GRND
GRND
Q4 25
8.42×
Q3 25
3.94×
Q2 25
1.51×
Q1 25
0.90×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
GRND
GRND
Operating Cash FlowLast quarter
$28.6M
$24.8M
Free Cash FlowOCF − Capex
$28.5M
$24.5M
FCF MarginFCF / Revenue
33.5%
19.5%
Capex IntensityCapex / Revenue
0.1%
0.2%
Cash ConversionOCF / Net Profit
1.47×
1.22×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M
$140.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
GRND
GRND
Q4 25
$28.6M
$24.8M
Q3 25
$-46.5M
$55.4M
Q2 25
$-43.4M
$37.5M
Q1 25
$-47.8M
$23.8M
Q4 24
$-134.6M
$29.5M
Q3 24
$-29.4M
$29.1M
Q2 24
$-30.2M
$15.8M
Q1 24
$-29.1M
$20.4M
Free Cash Flow
FDMT
FDMT
GRND
GRND
Q4 25
$28.5M
$24.5M
Q3 25
$-46.6M
$55.2M
Q2 25
$-43.4M
$37.3M
Q1 25
$-48.4M
$23.7M
Q4 24
$-138.4M
$29.3M
Q3 24
$-31.2M
$28.8M
Q2 24
$-30.6M
$15.7M
Q1 24
$-29.8M
$20.3M
FCF Margin
FDMT
FDMT
GRND
GRND
Q4 25
33.5%
19.5%
Q3 25
-51765.6%
47.7%
Q2 25
-289620.0%
35.8%
Q1 25
-345635.7%
25.2%
Q4 24
-13837100.0%
30.0%
Q3 24
-1038966.7%
32.2%
Q2 24
-611840.0%
19.0%
Q1 24
-106421.4%
26.9%
Capex Intensity
FDMT
FDMT
GRND
GRND
Q4 25
0.1%
0.2%
Q3 25
101.1%
0.2%
Q2 25
440.0%
0.2%
Q1 25
4507.1%
0.1%
Q4 24
378600.0%
0.3%
Q3 24
59266.7%
0.4%
Q2 24
6980.0%
0.2%
Q1 24
2535.7%
0.3%
Cash Conversion
FDMT
FDMT
GRND
GRND
Q4 25
1.47×
1.22×
Q3 25
1.80×
Q2 25
2.25×
Q1 25
0.88×
Q4 24
Q3 24
1.18×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FDMT
FDMT

Segment breakdown not available.

GRND
GRND

License And Service$102.9M82%
Advertising$23.1M18%

Related Comparisons